- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01718548
The Effects of Cordyceps Sinensis and Lingzhi on Cardiovascular Fitness and Cognitive Function
October 29, 2012 updated by: Hillel Yaffe Medical Center
Cordyceps Sinensis (CS) and Lingzhi extracts have been used in Chinese Medicine for many years for treatment of a variety of conditions.
The aim of this study is to evaluate the effects of oral ingestion of CS and Lingzhi extracts of a period of 28 days on cardiopulmonary fitness and cognitive functioning in young, healthy physical education students.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Netanya, Israel
- Wingate Institute
-
Contact:
- Sharon Tsuk, PhD
- Phone Number: 09-8639235
- Email: sharontsuk1@gmail.com
-
Principal Investigator:
- Sharon Tsuk, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Physical education students
Exclusion Criteria:
- All others
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: CS and Lingzhi
CS liquid (each dosage is a bottle of liquid containing 30 ml: comprising 75% of CS, 6% Lingzhi, 6% shitake, 5% bamboo shoot, 2% honey, 0.1% potassium sorbet and 5.9% pure water) and Lingzhi capsule (each capsule contains 620mg of: 52.42% Lingzhi, 28.23% CS, and 19.35% soy gel ) ; one quarter bottle of CS to be ingested twice a day, and the Lingzhi capsule to be taken once a day, both for a period of 28 days.
|
|
Placebo Comparator: Placebo
Liquid tea ingested twice a day and flour-filled capsules ingested once a day over a period of 28 days
|
Placebo
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improvement in Cardiopulmonary Fitness after Ingestion of CS and Lingzhi Extracts
Time Frame: 28 days
|
Before and after 28-day ingestion of CS and Lingzhi extracts, subjects will undergo a graded exercise test on a treadmill and results will be compared.
|
28 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of CS and Lingzhi on Cognitive Functioning
Time Frame: 28 days
|
Before and after 28-day ingestion of CS and Lingzhi the subjects undergo computerized cognitive tests and results will be compared.
|
28 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Anticipated)
December 1, 2013
Study Completion (Anticipated)
December 1, 2013
Study Registration Dates
First Submitted
October 29, 2012
First Submitted That Met QC Criteria
October 29, 2012
First Posted (Estimate)
October 31, 2012
Study Record Updates
Last Update Posted (Estimate)
October 31, 2012
Last Update Submitted That Met QC Criteria
October 29, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- 0062-12-HYMC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Executive Function
-
University School of Physical Education in WroclawActive, not recruitingCognitive Function | Executive FunctionPoland
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Recruiting
-
University of North Carolina, Chapel HillSigma XiCompleted
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedExecutive FunctionUnited States
-
Universitaire Ziekenhuizen KU LeuvenUnited States Department of DefenseNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedExecutive FunctionUnited States
-
Rotman Research Institute at BaycrestUniversity of TorontoUnknown
-
University of Sao PauloSwiss Tropical & Public Health Institute; Grand Challenges Canada; Harvard University and other collaboratorsUnknown
-
National Taiwan University HospitalCompletedExecutive Function | NeurosciencesTaiwan
-
Tjhin WigunaDr Cipto Mangunkusumo General Hospital; Fakultas Kedokteran Universitas Indonesia and other collaboratorsCompleted
Clinical Trials on Cordyceps Sinensis (CS) and Lingzhi
-
Second Xiangya Hospital of Central South UniversityCompletedType 2 Diabetes Mellitus | Diabetic Kidney DiseaseChina
-
Chonbuk National University HospitalCompleted
-
Chonbuk National University HospitalCompleted
-
University of OxfordCompleted
-
Chulalongkorn UniversityCompleted
-
Chinese University of Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong... and other collaboratorsCompleted
-
London School of Hygiene and Tropical MedicineMedical Research Council; University of OxfordCompleted
-
Xuanwu Hospital, BeijingRecruitingParkinson DiseaseChina
-
Virginia Polytechnic Institute and State UniversityRecruiting
-
Chinese University of Hong KongCompleted